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Abstract Cerebral blood flow is highly sensitive to changes in CO2/H+ where an increase in
CO2/H
+ causes vasodilation and increased blood flow. Tissue CO2/H
+ also functions as the main
stimulus for breathing by activating chemosensitive neurons that control respiratory output.
Considering that CO2/H
+-induced vasodilation would accelerate removal of CO2/H
+ and potentially
counteract the drive to breathe, we hypothesize that chemosensitive brain regions have adapted a
means of preventing vascular CO2/H
+-reactivity. Here, we show in rat that purinergic signaling,
possibly through P2Y2/4 receptors, in the retrotrapezoid nucleus (RTN) maintains arteriole tone
during high CO2/H
+ and disruption of this mechanism decreases the CO2ventilatory response. Our
discovery that CO2/H
+-dependent regulation of vascular tone in the RTN is the opposite to the rest
of the cerebral vascular tree is novel and fundamentally important for understanding how
regulation of vascular tone is tailored to support neural function and behavior, in this case the drive
to breathe.
DOI: 10.7554/eLife.25232.001
Introduction
Cerebral blood flow is highly sensitive to changes in CO2/H
+. An increase in CO2/H
+ causes vasodila-
tion and increased blood flow, which in turn facilitates removal of excess CO2/H
+. This response,
known as vascular CO2 reactivity, serves to match blood flow with tissue metabolic needs
(Ainslie and Duffin, 2009). Maintaining tight control of brain CO2/H
+ levels is critical, as there is
only a narrow range that is conducive to normal neural function. For example, a modest alkalosis of
just 0.2 pH units can trigger seizure activity; conversely, a similar degree of acidification can inhibit
cortical activity (Schuchmann et al., 2006). Tissue CO2/H
+ levels are also regulated by respiratory
activity. This is accomplished by specialized subsets of neurons known as respiratory chemoreceptors
that are activated by an increase in CO2/H
+ (Guyenet and Bayliss, 2015). This information is then
relayed to respiratory centers to enhance breathing, and consequently facilitate removal of arterial
CO2 in the exhaled breath.
The retrotrapezoid nucleus (RTN) is a region critical for respiratory chemoreception
(Guyenet and Bayliss, 2015). This region contains a subset of neurons that are intrinsically sensitive
to changes in CO2/H
+ (Mulkey et al., 2004: Wang et al., 2013) and relay responses to further
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respiratory control regions, such as the ventral respiratory complex to control breathing rate, inspira-
tory amplitude, active expiration and airway patency (Guyenet and Bayliss, 2015; Silva et al.,
2016). Disrupting mechanisms by which RTN neurons sense CO2/H
+ abolishes ventilatory responses
to CO2 and results in severe apnea (Kumar et al., 2015). Interestingly, RTN astrocytes also support
chemoreception by providing a CO2/H
+-dependent purinergic drive that enhances activity of che-
mosensitive neurons (Gourine et al., 2010; Wenker et al., 2012). This function of RTN astrocytes is
unique to the RTN since astrocytes elsewhere do not respond similarly to changes in pH
(Gourine et al., 2010; Sobrinho et al., 2014).
For more than a century, vascular CO2 reactivity has been assumed to be a common feature of
the entire cerebrovascular tree (Ainslie and Duffin, 2009; Roy and Sherrington, 1890). However, if
CO2/H
+-induced vasodilation were to occur in chemosensitive regions it would accelerate removal
of tissue CO2/H
+ and effectively counter-regulate activity of respiratory chemoreceptors (Xie et al.,
2006). Therefore, we propose that regulation of vascular tone is specialized to support local neural
network function, and specifically that a chemoreceptor region like the RTN has evolved a means of
maintaining vascular tone during exposure to high CO2/H
+ in a manner that supports the drive to
breathe. Consistent with this, early studies showed that fast breath by breath changes in arteriole
CO2 correspond with changes in pH measured at the ventral medullary surface (Millhorn et al.,
1984), suggesting tissue pH in this region is not highly buffered, possibly because blood vessels in
this region do not dilate in response to CO2/H
+. Furthermore, considering that CO2/H
+-evoked ATP
release appears to be unique feature of RTN chemoreception (Gourine et al., 2010) and since ATP
can mediate vasoconstriction in other brain regions (Kur and Newman, 2014; Peppiatt et al.,
2006), we hypothesize that CO2/H
+-evoked ATP release will antagonize CO2/H
+-vasodilation in the
RTN, and thus prevent CO2/H
+ washout, further enhancing chemoreceptor function.
Consistent with this hypothesis, we find that arterioles in the RTN and cortex are differentially mod-
ulated by purinergic signaling during exposure to high CO2/H
+. Specifically, we show in vitro and in
vivo that exposure to CO2/H
+ caused vasoconstriction of RTN arterioles but vasodilation of cortical
eLife digest We breathe to help us take oxygen into the body and remove carbon dioxide. Our
cells use the oxygen to break down food to release energy, and as they do so they produce carbon
dioxide as a waste product. Cells release this carbon dioxide back into the bloodstream so that it
can be transported to the lungs to be breathed out. Carbon dioxide also makes the blood more
acidic; if the blood becomes too acidic, tissues and organs may not work properly.
The brain uses roughly 25% of the oxygen consumed by the body and is particularly sensitive to
the levels of gases and acidity in the blood. It has been known for more than a century that
increased carbon dioxide causes blood vessels in the brain to widen, allowing the excess carbon
dioxide to be carried away quickly. More recent work has shown that increased carbon dioxide also
activates neurons called respiratory chemoreceptors. These in turn activate the brain centers that
drive breathing, causing us to breathe more rapidly to help us remove surplus carbon dioxide.
But this scenario contains a paradox. If high levels of carbon dioxide cause widening of the blood
vessels in the brain regions that contain respiratory chemoreceptors, this should, in theory, wash out
that important stimulus, reducing the drive to breathe. So how does the brain prevent this unhelpful
response? By studying the brains of adult rats, Hawkins et al. show that different rules apply to the
brain centers that control breathing compared to other areas of the brain. In one such region, if the
blood becomes too acidic, support cells called astrocytes release chemical signals called purines.
This counteracts the tendency of high carbon dioxide levels to widen blood vessels in this region,
and instead causes these vessels to become narrower.
This mechanism ensures that local levels of carbon dioxide in respiratory brain centers remain in
tune with the demands of local networks, thereby maintaining the drive to breathe. The next
challenges are to identify the molecular mechanisms that control the diameter of blood vessels in
brain regions containing respiratory chemoreceptors, and to find out whether drugs that modulate
these mechanisms have the potential to treat some respiratory conditions.
DOI: 10.7554/eLife.25232.002
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arterioles. The CO2/H
+-response of RTN arterioles was blocked by bath application of a P2 receptor
blocker (pyridoxalphosphate-6-azophenyl-2’,4’-disulfonic acid; PPADS) and mimicked by a P2Y2/4
receptor agonist (UTPgS) but not a P2X receptor agonist (a,b-mATP), suggesting mechanism(s) under-
lying this response in the RTN involve purinergic signaling and downstream activation of P2Y2 and/or
P2Y4 receptors. To support the possibility that RTN vascular control contributes to respiratory behav-
ior, we show that disruption of purinergic regulation of vascular tone or application of a vasodilator
(SNP) to the RTN region decreased the ventilatory response to CO2, whereas application of vasocon-
strictors (phenylephrine or U46619) potentiated the central chemoreflex. These results suggest for the
first time that regulation of vascular tone in a respiratory chemoreceptor region is specialized to sup-
port the drive to breathe.
Results and discussion
We initially tested our hypothesis using the brain slice preparation optimized for detecting increases
or decreases in vascular tone (see Mateials and methods). For these experiments, we targeted arte-
rioles based on previously described criteria (Mishra et al., 2014; Filosa et al., 2004). Vessel diame-
ter was monitored continuously during exposure to 15% CO2 (pH = 6.9) under baseline conditions
and during purinergic receptor blockade with PPADS. Consistent with our hypothesis, we found
CO2/H
+ differentially regulates arteriole diameter in the RTN depending on the function of puriner-
gic receptors. For example, exposure to CO2/H
+ under control conditions resulted in a vasoconstric-
tion of  4.6 ± 0.6% (p<0.0001, N = 34 vessels) (Figure 1C) (estimated by Poiseuille’s law to
decrease blood flow by ~20%). Further, we found that CO2/H
+-induced constriction of RTN arterio-
les was retained in the presence of tetrodotoxin (TTX; 0.5 mM) to block neuronal action potentials
( 6.1 ± 1.6%, p=0.0103, N = 6 vessels), thus suggesting glutamatergic CO2/H
+-activated neurons
(Mulkey et al., 2004) are not requisite determinants of this response. Conversely, exposure to CO2/
H+ did not cause constriction of RTN arterioles during P2 receptor blockade with 5 mM PPADS ( 0.1
± 0.9%, p=0.4876, N = 8 vessels) (Figure 1A–C). We also tested effects of exogenous ATP to con-
firm that it functions as vasoconstrictor of RTN arterioles. Indeed, we found that exposure to ATP
(100 mM) resulted in a  5.8 ± 1.5% constriction (p=0.0018, N = 7 vessels) (Figure 1D–E). These
results show that purinergic signaling contributes to CO2/H
+-dependent control of RTN arterioles.
Purinergic receptors are expressed by a wide variety of cell types including neurons, astrocytes,
smooth muscle and endothelial cells; in the context of vascular control, the P2 receptors most com-
monly implicated in vasoconstriction are several members of the P2X family of ionotropic receptors
and metabotropic P2Y2, P2Y4 and P2Y6 (Burnstock and Ralevic, 2014). Since the concentration of
PPADS used above to block purinergic modulation of RTN arterioles has highest affinities for P2X
and P2Y2 and P2Y4 (Ralevic and Burnstock, 1998), to identify candidate P2 receptors that help
maintain RTN arteriole tone during exposure to CO2/H
+, we tested effects of a selective P2Y2 and
P2Y4 receptor agonist (UTPgS) (Lazarowski et al., 1996) and an agonist with high affinity for P2X
receptors (a,b-mATP) (Burnstock and Kennedy, 1985). We found that bath application of UTPgS
(0.5 mM) mimicked effects of CO2/H
+ by decreasing diameter of RTN arterioles ( 3.4 ± 0.6%,
p=0.0003, N = 8 vessels), whereas exposure to a,b-mATP (100 mM) minimally affected arteriole tone
(p=0.2113, N = 9 vessels) (Figure 1D–E). These results suggest that mechanism(s) underlying puri-
nergic-dependent control of RTN arterioles during high CO2/H
+ involve activation of Gq-coupled
P2Y2/4 receptors. To further support this possibility, we performed immunohistochemistry using
commercially available P2Y2 and P2Y4 specific antibodies in conjunction with cell-type specific
markers for endothelial cells (DyLight 594 Isolectin B4 conjugate; IB4), vascular smooth muscle cells
(a-smooth muscle actin; a-SMA), and astrocytes (anti-glial fibrillary acidic protein; GFAP). We
detected P2Y2 and P2Y4 immunoreactivity in close proximity to all three cell types associated with
RTN arterioles. For example, P2Y2 and P2Y4 labeling appeared as numerous intensely stained puncta
near endothelial cells and smooth muscle cells and as smaller more diffuse puncta near astrocytes
(Figure 1F–G). The expression of these receptors together with our functional evidence suggest
P2Y2/4 receptors contribute to purinergic-dependent vasoconstriction in the RTN during exposure to
CO2/H
+.
Considering that ATP and UTP breakdown products are known to affect vascular tone in other
brain regions (Burnstock and Ralevic, 2014), we also pharmacologically manipulated P1 receptors
and ectonucleotidase activity before or during exposure to CO2/H
+. We found that application of
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Figure 1. CO2/H
+-induced vasoconstriction of RTN arterioles is mediated by a purinergic dependent mechanism involving P2Y2/4 receptors. (A) trace of
an RTN arteriole diameter show that increasing CO2 in the perfusion media from 5% to 15% (balance air, in TTX) caused vasoconstriction under
baseline conditions but not in PPADS (5 mM). (B) example vessel image under baseline conditions and corresponding fluorescent intensity profile plots
also show that exposure to high CO2 decreased vessel diameter. Profile plot scale bars: 2000 a.u., 10 mm. (C) summarized results of RTN arteriole
responses to CO2/H
+ under baseline conditions (N = 34 vessels) and when P2-receptors were blocked (5 mM PPADS; N = 8 vessels), P1-receptors were
blocked (10 mM 8-PT; N = 7 vessels), or ectonucleotidase activity was inhibited (100 mM POM1; N = 5 vessels). (D) example diameter traces show RTN
arterioles constrict in response to bath application of ATP (100 mM) or the selective P2Y2/4 receptor agonist UTPgS (0.5 mM) but dilate when P1
receptors are activated by adenosine (Ado; 1 mM). (E) summary data plotted as % diameter change in response to ATP (N = 7 vessels), UTP (N = 8
vessels), a,b-mATP (100 mM, preferential P2X agonist; N = 9 vessels) or adenosine (N = 9 vessels). (F–G), immunoreactivity for P2Y2 (F) and P2Y4 (G)
receptors was detected as brightly label puncta near endothelial cells (DyLight 594 Isolectin B4 conjugate; IB4), arteriole smooth muscle (a-smooth
muscle actin; aSMA), and astrocytes (glial fibrillary acidic protein; GFAP) associated with arterioles in the RTN (N = 3 animals). Arrows identify receptor
labeling close to endothelial or smooth muscle cells and arrowhead identifies receptor labeling of astrocyte processes. Scale bar 10 mM. Hash marks
designate a difference in mm from baseline as determined by RM-one-way ANOVA and Fishers LSD test or paired t-test and asterisks identify
differences in CO2/H
+-induced % change under baseline conditions vs in the presence of PPADS (C) or ATP vs specific agonist-induced % change (E)
(one-way ANOVA and Fishers LSD test); one symbol = p<0.05, two symbols = p<0.01, three symbols = p<0.001, four symbols = p<0.0001.
DOI: 10.7554/eLife.25232.003
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adenosine (1 mM) under control conditions caused vasodilation of RTN arterioles (2.6 ± 0.6%;
p=0.0027, N = 9 vessels) (Figure 1D–E); however, blockade of adenosine receptors with 8-phenyl-
theophylline (8-PT; 10 mM) had negligible effects on CO2/H
+-induced vasoconstriction ( 3.2 ± 0.4%,
p=0.0002, N = 7 vessels) (Figure 1C). Likewise, incubation in sodium metatungstate (POM 1; 100
mM) to inhibit ectonucleotidase activity also minimally affected the CO2/H
+-vascular response of
RTN arterioles ( 3.1 ± 0.6%, p=0.0195, N = 5 vessels) (Figure 1C). These results suggest that nucle-
oside metabolites are not essential for CO2/H
+-dependent regulation of vascular tone in the RTN.
Previous evidence (Gourine et al., 2010) suggests CO2/H
+-evoked ATP release from RTN astro-
cytes is mediated by intracellular Ca2+. Therefore, in the absence of high CO2, pharmacological acti-
vation of RTN astrocytes should trigger arteriole constriction by a purinergic-dependent mechanism.
We test this by bath application of t-ACPD (50 mM), an mGluR agonist used to elicit Ca2+ elevations
in cortical astrocytes (Filosa et al., 2004; Zonta et al., 2003). Exposure to t-ACPD caused vasocon-
striction of RTN arterioles under baseline conditions ( 3.5 ± 0.5%, p=0.0007, N = 7) but not in
PPADS ( 0.6 ± 0.4%, p=0.2163, N = 7 vessels) (Figure 2A–B,E). These results are consistent with
our hypothesis that purinergic signaling, possibly from CO2/H
+-sensitive RTN astrocytes
(Gourine et al., 2010), serves to maintain tone of arteriole in the RTN during hypercapnia.
In marked contrast to the RTN, we found that cortical arterioles dilated in response to astrocyte
activation by t-ACPD. For example, bath application of t-ACPD (50 mM) dilated cortical arterioles by
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Figure 2. t-ACPD-mediated astrocyte activation has opposite effects on arteriole diameter in the RTN and cortex.
(A) diameter trace of an RTN arteriole show the response of an RTN arteriole to t-ACPD (50 mM) under baseline
conditions and during P2-receptor blockade with PPADS (5 mM). (B) example RTN vessel image under baseline
conditions and corresponding fluorescent intensity profile plots also show that exposure to tACPD decreased
vessel diameter. (C) diameter trace of an cortical arteriole and corresponding vessel image with example profile
plots (D) show that exposure to tACPD (50 mM) increase cortical arteriole diameter. Profile plot scale bars: 2000 a.
u., 10 mm. (E) summary from the RTN (N = 7 vessels) and cortex (N = 5 vessels) data show that t-ACPD caused
vasoconstriction of RTN arterioles under control conditions but not in the presence of PPADS, suggesting
purinergic signaling most likely from astrocytes mediate constriction of arterioles in the RTN. Conversely, in the
cortex t-ACPD caused vasodilation. ##, difference in mm from baseline (paired t-test, p<0.01). ###, difference in mm
from baseline (RM-one-way ANOVA and Fishers LSD test, p<0.001). **, difference in t-ACPD-induced % change
under baseline conditions vs in PPADS (paired t-test, p<0.01).
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3.2 ± 0.6% (p=0.0030, N = 5 vessels) (Figure 2C–E). This response is consistent with previous cortical
studies (Filosa et al., 2004; Zonta et al., 2003), and suggests that astrocytes in the RTN and cortex
have fundamentally different roles in regulation of vascular tone. Also consistent with previous work
(Ainslie and Duffin, 2009), we confirmed that cortical arterioles dilate in response to CO2/H
+(5.7 ±
1.1%, p=0.0057, N = 11 vessels) (Figure 3A–C). Interestingly, we also found that the CO2/H
+-vascu-
lar response of cortical arterioles was reduced to 0.5 ± 0.5% in PPADS (p=0.004, N = 6 vessels)
(Figure 3A–C), suggesting involvement of endogenous ATP in cortical arteriole CO2/H
+-dilation. As
in the RTN, we also found that endothelial cells, smooth muscle and astrocytes associated with corti-
cal arterioles were immunoreactive for P2Y2 and P2Y4 (Figure 3D–E), suggesting the differential
roles of purinergic signaling in these regions is not due to the presence or absence of P2Y2 and
P2Y4. However, since the vascular responses to activation of P2Y2/4 can vary depending on which
cells express the receptor (Burnstock and Ralevic, 2014), it remains possible that differential
expression of P2Y2/4 by endothelial and smooth muscle may mediate vasodilation in the cortex and
constriction in the RTN, respectively. It is also possible that other purinergic receptors contribute to
regulation of arteriole tone in these regions. For example, endothelial P2Y1 receptors are known to
mediate vasodilation in the cortex (Burnstock and Ralevic, 2014). However, we found that in vivo
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Figure 3. Cortical arterioles dilate in response to CO2/H
+. (A) diameter trace of a cortical arteriole with an example vessel image and fluorescence
profile plots (B) show that exposure to CO2/H
+ caused vasodilation under baseline conditions and this response was blunted by PPADS (5 mM). Profile
plot scale bars: 2000 a.u., 10 mm. (C) summary data show CO2/H
+-induced vasodilation of cortical arterioles under bassline conditions (N = 11 vessels)
but not in PPADS (N = 6 vessels). (D–E), immunoreactivity for P2Y2 (D) and P2Y4 (E) receptors was detected as brightly label puncta near endothelial
cells (DyLight 594 Isolectin B4 conjugate; IB4), arteriole smooth muscle (a-smooth muscle actin; aSMA), and astrocytes (glial fibrillary acidic protein;
GFAP) associated with cortical arterioles (N = 3 animals). Arrows identify receptor labeling close to endothelial or smooth muscle cells and arrowheads
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+-
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application of a selective P2Y1 receptor blocker (MRS2179, 100 mM) had no measurable effect on
the CO2/H
+ response of pial vessels in the RTN ( 3.7 ± 0.8%, vs. saline plus CO2:  4.3 ± 0.7%;
p=0.068; N = 5 vessels) or cortex (4.8 ± 0.5%, vs. saline plus CO2: 4.7 ± 0.6%; p=0.24; N = 5 vessels)
(data not shown). Alternatively, arachidonic acid metabolites are also potent regulators of vascular
tone (MacVicar and Newman, 2015) and recent evidence showed that CO2/H
+-mediated vasodila-
tion in the cortex and hippocampus involved activation of cyclooxygenase-1 and prostaglandin E2
release by astrocytes (Howarth et al., 2017). Considering that purinergic signaling can elicit Ca2+
responses in astrocytes to facilitate prostaglandin E2 synthesis (Xu et al., 2003), it remains possible
that purinergic signaling contributes to cortical CO2/H
+ dilation by influencing synthesis and release
of prostaglandin E2 by astrocytes. However, currently the cellular and molecular basis of purinergic
dilation in the cortex remains unknown.
To determine whether regulation of vascular tone in the RTN impacts respiratory behavior, we
pharmacologically manipulated RTN vessels in anesthetized rats while simultaneously measuring sys-
temic blood pressure and diaphragm EMG activity (as a measure of respiratory activity) during expo-
sure to high CO2. We found that localized application of the vasoconstrictors phenylephrine (Phe; 1
mM) or U46619 (1 mM) to the ventral medullary surface (VMS) enhanced the ventilatory response to
CO2 by increasing diaphragm electromyogram (EMG) amplitude 15 ± 2% and 18 ± 1.8%, respec-
tively (Figure 4A–C) (p=0.02; N = 6 animals) but with no change in frequency (Figure 4D) (p>0.05;
N = 6 animals). Also consistent with the possibility that increased blood flow will facilitate removal of
tissue CO2/H
+, and thus decrease the stimulus to chemosensitive neurons, we found that VMS appli-
cation of the vasodilator sodium nitroprusside (SNP; 1 mM) decreased ventilatory response to CO2
by decreasing diaphragm amplitude by 24 ± 2.6% (Figure 4A–C) (p=0.02; N = 6 animals) but with
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no change in frequency (Figure 4D) (p>0.05; N = 6 animals). These treatments had negligible effect
on systemic mean arterial pressure (MAP) (Phe: 110 ± 2; SNP: 110 ± 2; U4619: 108 ± 3 vs. saline:
109 ± 2 mmHg; p>0.05) (Figure 4E). These results are consistent with the possibility that regulation
of vascular tone in the RTN can influence respiratory output. However, we cannot exclude potential
direct effects of these drugs on activity of neurons or astrocytes in the region. For example, phenyl-
ephrine can directly stimulate activity of chemosensitive RTN neurons (Kuo et al., 2016). Therefore,
effects of phenylephrine on chemoreception likely involves both vasoconstriction and direct neural
activation. It remains to be determined whether U46619 or SNP also affect activity of neurons or
astrocytes in the RTN.
To determine whether purinergic signaling regulates CO2/H
+-mediated constriction in vivo, we
first measured the diameter of pial vessels on the VMS in the region of the RTN or on the surface of
the cortex during exposure to high CO2 under control conditions and when P2 receptor are blocked
with PPADS (10 mM). Consistent with our in vitro data, we found that increasing end-expiratory CO2
to 9.5–10%, which corresponds with an arterial pH of 7.2 pH units (Guyenet et al., 2005), con-
stricted VMS vessels by  4.5 ± 0.5% (p=0.014, N = 5 animals) (Figure 5A–B). However, when P2-
receptors are blocked with PPADS (10 mM), increasing inspired CO2 resulted in a vasodilation of 4.3
± 0.4% (Figure 5A–B) (p=0.036; N = 5 animals). This suggests that in the RTN, purinergic-mediated
vasoconstriction is working against a background CO2/H
+ dilation, possibly mediated by a cyclooxy-
genenase/prostroglandine E2-dependent mechanism as described elsewhere in the brain
(Howarth et al., 2017). Therefore, disruption of CO2/H
+ dilation would be expected to enhance
purinergic-dependent vasoconstriction of RTN arterioles, and thus increase baseline breathing and
the ventilatory response to CO2. Consistent with this, administration of a cyclooxygenase inhibitor
(indomethacin) has been shown to increase baseline breathing and the ventilatory response to CO2
in humans (Xie et al., 2006). However, it is also possible that decreasing cerebral blood flow glob-
ally by indomethacin treatment or cerebral ischemia (Chapman et al., 1979) will cause widespread
acidification leading to enhanced activation of multiple chemoreceptor regions including those out-
side the RTN (Nattie and Li, 2012), thus further increasing chemoreceptor drive. It should also be
noted that global disruption of cerebrovascular CO2/H
+ reactivity as associated with certain patho-
logical states including heart failure and stroke (Yonas et al., 1993; Howard et al., 2001) or by sys-
temic administration of indomethacin can increase chemoreceptor gain to the extent that breathing
becomes unstable (Fan et al., 2010; Xie et al., 2009). These results underscore the need to under-
stand how CO2/H
+ regulates vascular tone at other levels of the respiratory circuit.
Also consistent with our slice data, we found that exogenous application of ATP (1 mM) or UTPgS
(1 mM) constricted VMS vessels by  5.1 ± 0.6% and  5.0 ± 0.5%, respectively (p=0.001; N = 5 ani-
mals) (Figure 5A). Conversely, cortical pial vessels dilated in response to an increase in inspired CO2
under control conditions (5 ± 0.5%) and after application of 10 mM PPADS (3.2 ± 0.3%) (Figure 5C)
(p=0.03; N = 5 animals); however, the CO2/H
+-induced vasodilation of cortical vessels was blunted
in the presence of PPADS (p=0.03; N = 5 animals), suggesting endogenous purinergic signaling may
facilitate dilation of cortical vessels in response to CO2/H
+. However, we failed to mimic this
response by exogenous application of purinergic agonists; exposure to ATP (1 mM) or UTPgS (1
mM) constricted cortical vessels by  4.9 ± 0.7% and  4.1 ± 0.7%, respectively (p=0.024; N = 5 ani-
mals). These divergent results are not entirely unexpected since we detected P2Y2 and P2Y4 immu-
noreactivity on endothelial cells and smooth muscle of cortical arterioles (Figure 3D–E), and
exogenous application of P2 agonists may activate P2 receptors not necessarily targeted by endoge-
nous purinergic signaling. Future work is required to identify the source of purinergic drive and
effector P2 receptors contributing to vascular CO2/H
+-reactivity in the cortex.
In addition, as previously described (Gourine et al., 2005), we found that application of PPADS
(10 mM) to the RTN blunted the ventilatory response to CO2 both in terms of DiaEMG frequency
(82 ± 3, vs. saline: 97 ± 4%) (p=0.042, N = 5) and amplitude (83 ± 6, vs. saline: 100 ± 5%) (p=0.035,
N = 5) (Figure 5D–E). Considering that RTN manipulations of vascular tone preferentially affect
respiratory amplitude (Figure 4A–D), whereas application of PPADS to the same region, which likely
disrupts both direct excitatory effects of ATP on RTN chemoreceptors (Wenker et al., 2012) and
indirect effects of ATP on vascular tone (Figure 5A), blunts respiratory frequency and amplitude,
suggests that purinergic signaling in the RTN might regulate discrete aspects of respiratory output.
In the cortex, application of PPADS had no measurable effect on CO2-induced changes in DiaEMG
frequency (p=0.33, N = 5 animals) and amplitude (p=0.42, N = 5) (Figure 5F). Together with
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previous evidence, these findings suggest that purinergic signaling contributes to RTN chemorecep-
tion by directly activating RTN neurons (Gourine et al., 2010) and indirectly by opposing CO2/H
+-
vasodilation.
It should be acknowledged that our study is limited to the use of pharmacological tools that
potentially have off-target effects. We have minimized this concern by (i) using low concentrations of
PPADS that are reported to be specific for P2 receptor’s (Lorier et al., 2004); (ii) mimicking CO2/
H+-induced vasoconstriction in vitro and in vivo by exogenous application of ATP and a specific
P2Y2/4 receptor agonist (UTPgS), but not by a non-specific P2X receptor agonist (a,b-mATP); (iii) con-
firming that candidate P2Y2 and P2Y4 receptors are expressed in the RTN at the astrocyte-arteriole
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Figure 5. Purinergic signaling opposes CO2/H
+-dilation of VMS pial vessels in vivo and contributes to the ventilatory response to CO2. (A) summary
data plotted as % change in RTN pial vessel diameter in response to an increase in end expiratory CO2 after VMS application of saline (100 nL; N = 5
animals) or PPADS (10 mM, 100 nL; N = 5 animals). Also shown are the vascular responses to VMS application of ATP (1 mM, 100 nL; N = 5) and UTPgS
(1 mM, 100 nL; N = 5 animals). (B) Photomicrographs (40X) show pial vessel distribution on the VMS, arrow; representative vessel analyzed. (C) Summary
data shows the response of cortical pial vessels to CO2 after local application of saline or PPADS (10 mM, 100 nL; N = 5 animals). Also shown are
vascular responses to exogenous application of ATP (1 mM - 100 nL; N = 5 animals) or UTPgS (1 mM, 100 nL; N = 5). (D) End expiratory CO2 (EtCO2),
arterial pressure (AP) and diaphragm EMG (DiaEMG) traces show that bilateral VMS application of PPADS (10 mM, 100 nL) attenuated the ventilatory
response to CO2. (E) summary data show CO2-induced changes in DiaEMG frequency and amplitude after bilateral VMS application of saline and PPADS
(10 mM; N = 5 animals). (F) summary data show that PPADS (10 mM) application to the cortex surface had no measurable effect on CO2-induced
changes in DiaEMG frequency and amplitude (N = 5 animals). Hash marks designate a difference in mm from baseline (RM-ANOVA followed by
Bonferroni multiple-comparison test, #, p<0.05). Asterisks identify a difference in CO2/H
+–induced % change under control conditions (saline) vs in the
presence of PPADS (RM-ANOVA followed by Bonferroni multiple-comparison test, *, p<0.05; **, p<0.01) (panels A and C) or paired t-test (panel E, *,
p<0.05).
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interface; and (iv) for in vitro experiments by confirming that CO2/H
+-induced vasoconstriction was
retained when neuronal action potentials were blocked with TTX. Therefore, our results suggest that
purinergic signaling possibly through P2Y2/4 receptors in the RTN provides specialized control of
vascular tone by preventing CO2/H
+-induced dilation. Our results also suggest that regulation of
vascular tone in the RTN contributes functionally to the ventilatory response to CO2. This is the first
evidence to suggest that regulation of vascular tone in a chemoreceptor region contributes to the
drive to breathe. This discovery may be of fundamental importance to understanding how regulation
of vascular tone impacts neural network function and ultimately behavior.
Materials and methods
Brainstem slice preparation
All procedures were performed in accordance with National Institutes of Health and University of
Connecticut Animal Care and Use Guidelines. A total of 93 adult Sprague Dawley rats (60–100 days
of age) were used for in vitro experiments. Animals were decapitated under isoflurane anesthesia,
and transverse brainstem slices (200 mm) were prepared using a vibratome in ice-cold substituted
artificial cerebrospinal fluid (aCSF) solution containing (in mm): 130 NaCl, 3 KCl, 2 MgCl2, 2 CaCl2,
1.25 NaH2PO4, 26 NaHCO3, and 10 glucose, with 0.4 mM L-ascorbic acid added (all Sigma-Aldrich).
Slices were incubated for ~30 min at 37˚C and subsequently at room temperature in aCSF. Prior to
imaging slices were incubated for 1 hr with 10 mg/ml TRITC-lectin conjugate (Sigma-
Aldrich, St. Louis, MO) or 6 mg/ml DyLight 594 Isolectin B4 conjugate (Vector Labortories) to label
endothelial cells as previously described (Mishra et al., 2014). Slicing solutions were equilibrated
with a high oxygen carbogen gas (95% O2-5% CO2) (Mulkey et al., 2001).
Imaging of arterioles in brainstem slices
An individual slice containing the RTN was transferred to a recording chamber mounted on a fixed-
stage microscope (Zeiss Axioskop FS) and perfused continuously (~2 ml min 1) with aCSF bubbled
with 5% CO2, 21% O2 (balance N2; pHo ~7.35; 37
0 C) (Gordon et al., 2008). Hypercapnic solution
was made by equilibrating aCSF with 15% CO2, 21% O2 (balance N2; pHo ~6.90; 37
0 C). Arterioles
were identified as previously described (Mishra et al., 2014; Filosa et al., 2004) by the following cri-
teria: clear evidence of vasomotion under IR-DIC, bulky fluorescent labeling and a thick layer of
smooth muscle surrounding the vessel lumen. Vessels that appeared collapsed and unhealthy were
excluded, as were those with little fluorescence staining and thin walls, indicative of a lack of smooth
muscle (Mishra et al., 2014). All arterioles selected for analysis had a resting luminal diameter of
between 8–45 mm; RTN vessels were located within 200 mm of the ventral surface and below the cau-
dal end of the facial motor nucleus and cortical vessels were located in layers 1–3.
For an experiment, fluorescent images were acquired at a rate of 1 frame/20 s using a x40 water
objective, a Clara CCD Andor camera and NIS Elements software. To induce a partially constricted
state we bath applied a thromboxane A2 receptor agonist (U46619; 125 nM; Sigma-Aldrich, St.
Louis, MO). At this concentration, U46619 has been shown to decrease vessel diameter by 20–30%
under similar experimental conditions, thus allowing assessment of both vasodilation and vasocon-
striction (Filosa et al., 2004; Girouard et al., 2010). In the continued presence of U-46619, we then
characterized the effects of hypercapnia, ATP (100 mM; Sigma-Aldrich, St. Louis, MO), a,b-methyle-
neATP (100 mM), UTPgS (0.5 mM), and adenosine (1 mM), or the mGluR agonist t-ACPD ((±) 1-amino-
cyclopentane-trans-1,3-dicarboxylic acid; 50 mM) alone or in the presence of P2-recepetor blocker
PPADS (5 mM; Tocris Bioscience, Minneapolis, MN), the P1 receptor antagonist 8-Phenyltheophylline
(8-PT; 10 mM; Sigma) or the Ecto-NTPDase antagonist sodium metatungstate (POM 1; 100 mM; Toc-
ris). In a subset of experiments we also tested CO2, ATP and PPADS in the presence of TTX (0.5 mM;
Alomone Laboratories). As previously described (Girouard et al., 2010), at the end of each experi-
ment we assessed arteriole viability by inducing a constriction with a high K+ solution (60 mM) and
then maximal dilation with a Ca2+ free solution containing EGTA (5 mM), papaverine (200 mM, a
phosphodiesterase inhibitor) and diltiazem (50 mM, to block L-type Ca channels). Vessels from both
regions of interest (RTN and cortex) show similar responses to these conditions, and vessels that did
not respond were excluded from analysis.
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Immunohistochemistry
Rat brain slices were prepared from three rats and labelled with DyLight 594 Isolectin B4 conjugate
as above followed by immersion fixation overnight in 1% paraformaldehyde in pH 7.4 PBS at 4˚C.
Excess fixative was removed by three washes in PBS, and prior to antibody incubations, tissue sec-
tions were treated to unmask epitopes with 0.2 mg/ml pepsin (Sigma-Aldrich, St. Louis, MO) in 0.2
M HCl for 10 mins at 37˚C (Corteen et al., 2011) followed by three washes in PBS for P2Y4 labelling
only. A blocking stage was then performed by incubating tissue in 10% normal horse serum in PBS
with 10% Triton X-100 (Sigma-Aldrich, St. Louis, MO) for 1 hr at room temperature (RT). Sections
were then incubated overnight at RT with primary antibodies diluted in blocking solution as follows:
1:200 rabbit anti-P2Y2 (RRID: AB_2040078) or P2Y4 receptor (RRID: AB_2040080) (Alomone
Labs, Alomone Labs, Jerusalem Israel), 1:200 chicken anti-glial fibrillary acidic protein (RRID: AB_
177521) (Chemicon) and 1:500 mouse anti-a-smooth muscle actin (RRID: AB_262054) (Sigma-Aldrich,
St. Louis, MO). After washes in PBS, tissues were incubated for 1 hr at RT with the appropriate sec-
ondary antibodies raised in donkey, conjugated with 488DyLight 1:800 (RRID: AB_2492289),
405DyLight 1:200 (RRID: AB_2340373) or Cy5 1:500 (RRID: AB_2340820) (Jackson Immunoresearch
Laboratories). Sections were washed in PBS again before being mounted with Vectasheild (Vector-
Labs). Images were acquired using a Nikon A1R confocal microscope (Nikon Instruments), with mini-
mal background staining observed in the control reactions where primary antibodies were omitted
or P2 receptor antibodies were pre-absorbed with control antigen prior to exposure to tissues. For
confocal photomicrographs, two-dimensional flattened images of the projected z-stacks are
presented.
In vivo preparation
Animal use was in accordance with guidelines approved by the University of Sa˜o Paulo Animal Care
and Use Committee. A total of 21 adult male Wistar rats (60–90 days of age; 270–310 g) were used
for in vivo experiments. General anesthesia was induced with 5% halothane in 100% O2. A tracheos-
tomy was made and the halothane concentration was reduced to 1.4–1.5% until the end of surgery.
The femoral artery was cannulated (polyethylene tubing, 0.6 mm o.d., 0.3 mm i.d., Scientific Com-
modities) for measurement of arterial pressure (AP). The femoral vein was cannulated for administra-
tion of fluids and drugs. Rats were placed supine onto a stereotaxic apparatus (Type 1760; Harvard
Apparatus) on a heating pad and core body temperature was maintained at a minimum of 36.5˚C via
a thermocouple. The trachea was cannulated. Respiratory flow was monitored via a flow head con-
nected to a transducer (GM Instruments) and CO2 via a capnograph (CWE, Inc,) connected to the
tracheal tube. Paired EMG wire electrodes (AM-System) were inserted into the diaphragm muscle to
record respiratory-related activity. After the anterior neck muscles were removed, a basio-occipital
craniotomy exposed the ventral medullary surface, and the dura was resected. After bilateral vagot-
omy, the exposed tissue around the neck and the mylohyoid muscle was covered with mineral oil to
prevent drying. Baseline parameters were allowed to stabilize for 30 min prior to recording.
In vivo recordings of physiological variables
Mean arterial pressure (MAP), diaphragm muscle activity (DiaEMG) and end-expiratory CO2 (etCO2)
were digitized with a micro1401 (Cambridge Electronic Design), stored on a computer, and proc-
essed off-line with version 6 of Spike 2 software (Cambridge Electronic Design). Integrated dia-
phragm activity (
Ð
DiaEMG) was collected after rectifying and smoothing (t = 0.03) the original signal,
which was acquired with a 300–3000 Hz bandpass filter. Noise was subtracted from the recordings
prior to performing any calculations of evoked changes in DiaEMG. A direct physiological comparison
of the absolute level of DiaEMG activity across nerves is not possible because of non-physiological
factors (e.g., muscle electrode contact, size of muscle bundle) and the ambiguity in interpreting how
a given increase in voltage in one EMG relates to an increase in voltage in another EMG. Thus, mus-
cle activity was defined according to its baseline physiological state, just prior to their activation.
The baseline activity was normalized to 100%, and the percent change was used to compare the
magnitude of increases or decreases across muscle from those physiological baselines.
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In vivo experimental protocol
Each in vivo experiment began by testing responses to hypercapnia by adding pure CO2 to the
breathing air supplied by artificial ventilation. In each rat, the addition of CO2 was monitored to
reach a maximum end-expiratory CO2 between 9.5% and 10%, which corresponds with an estimated
arterial pH of 7.2 based on the following equation: pHa = 7.955–0.7215  log10 (ETCO2)
(Guyenet et al., 2005). This maximum end-expiratory CO2 was maintained for 5 min and then
replaced by 100% O2.
To determine whether local regulation of vascular tone in the region of the RTN contributes to
the CO2/H
+-dependent drive to breathe, we made bilateral injections of saline, phenylephrine (Phe,
1 mM), U46619 (1 mM) or sodium nitroprusside (SNP, 1 mM) while monitoring DiaEMG amplitude and
frequency. These drugs were diluted to 1 mM with sterile saline (pH 7.4) and applied using single-
barrel glass pipettes (tip diameter of 25 mm) connected to a pressure injector (Picospritzer III, Parker
Hannifin Corp, Cleveland, OH). For each injection, we delivered a volume of 100 nl over a period of
5s. Injections in the VMS region were placed 1.9 mm lateral from the basilar artery, 0.9 mm rostral
from the most rostral hypoglossal nerve rootlet, and at the VMS. The second injection was made 1–2
min later at the same level on the contralateral side. In separate series of experiments saline, ATP (1
mM), UTPgS (1 mM) or PPADS (10 mM) were applied similarly to the VMS to test the effect of P2-
blockade on vascular CO2/H
+ reactivity and the ventilatory response to CO2. A cranial optical win-
dow was prepared using standard protocols previously described (Kim et al., 2015). Briefly, a dental
drill (Midwest Stylus Mini 540S, Dentsply International) was used to thin a circumference of a 4–5
mm-diameter circular region of the skull over somatosensory cortex (stereotaxic coordinates: AP:
 1.8 mm from bregma and ML: 2.8 mm lateral to the midline). For the VMS, the anterior neck
muscles were removed, a basio-occipital craniotomy exposed the ventral medullary surface, and the
dura was resected. Pial vessels in the VMS had an average and were located 1.9 mm lateral from the
basilar artery and 0.9 mm rostral to the most rostral portion of the hypoglossal nerve rootlet. Both
thinned bone were lifted with forceps. The surface of the cortex or the VMS were cleaned with
buffer containing (in mmol/L) the following: 135 NaCl, 5.4 KCl, 1 MgCl2, 1.8 CaCl2, and 5 HEPES, pH
7.3., and a chamber (home-made 1.1-cm-diameter plastic ring was glued with dental acrylic cement
attached to a baseplate). The chamber was sealed with a circular glass coverslip (#1943–00005,
Bellco). The baseplate was affixed to the Digital Camera (Sony, DCR-DVD3-5) and a light microscope
was used for vessel imaging (x40 magnification).
Image analysis
Vessel diameter was determined offline using ImageJ. For in vitro experiments, stack registration
and selection of linear regions of interest (ROIs) (three regions per arteriole) was carried out. Linear
ROI’s were used to create a fluorescent intensity profile plot as described previously (Mishra et al.,
2014) and a macro (available at https://github.com/omsai/blood-vessel-diameter [Nanda, 2017];
copy archived at https://github.com/elifesciences-publications/blood-vessel-diameter).was used to
determine the peak-peak distance as a measure of vessel diameter for each frame. In most cases, we
also confirmed vessel diameter by manually measuring at least one point per frame. In vivo data was
also analyzed using three linear ROI’s drawn perpendicular to the vessel in each image and the
Diameter plug-in function in ImageJ was used to calculate changes in diameter (Kim et al., 2015;
Fischer et al., 2010).
Data analysis and statistics
All in vitro images were calibrated and pixel distances converted to diameter (mM) and these values
were used for analysis of CO2/H
+ or agonist-induced changes in vessel diameter from baseline by
RM-one-way ANOVA and Fishers LSD test or paired t-test. Hash marks were used to identity differ-
ences from baseline (vasoconstriction or vasodilation). Mean percent changes in vessel diameter was
used to compare between agonist responses or CO2/H
+ responses under control conditions vs dur-
ing purinergic receptor blockade or in the presence of an ectonucleotidase inhibitor by one-way
ANOVA and Fishers LSD test or t-test. Asterisks were used to identify differences in % change in ves-
sel diameter. For in vivo experiments, respiratory muscle activity was calculated as the mean ampli-
tude of the integrated DiaEMG over 20 respiratory cycles. To obtain control values, the 20 cycles
preceding each experimental manipulation for all parameters were averaged. Under hypercapnic
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conditions, measurements from the 20 cycles preceding stimulus cessation were averaged. Respira-
tory frequency (fR) was (1/(inspiratory time + expiratory time). Differences in the ventilatory response
to CO2 were determined using either paired t-test or one-way analysis of variance (ANOVA) fol-
lowed by the Bonferroni multiple-comparisons as appropriate. Power analysis was used to determine
sample size, all data sets were tested for normality using Shapiro-Wilk test. All data values are
expressed as means ± SEM and specific statistical test and relevant p values are reported in the text
and figure legends.
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